Reconsidering the criteria for evaluating proposed screening programs: Reflections from 4 current and former members of the U.S. preventive services task force

Epidemiologic Reviews

Volumn 33, Issue 1, 2011, Pages 20-35

  Harris, Russell ^a,b,c   Sawaya, George F ^d   Moyer, Virginia A ^e   Calonge, Ned ^f  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c IL   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e TEXAS CHILDREN S HOSPITAL   (United States)

^f NONE   (United States)

Author keywords

evaluation studies as topic; evidence based practice; health planning guidelines; mass screening; outcome assessment (health care); quality of health care; review; risk assessment

Indexed keywords

ADVERSE OUTCOME; ARTICLE; BOOK; BREAST CANCER; CANCER SCREENING; COLORECTAL CANCER; CORONARY ARTERY ATHEROSCLEROSIS; DIABETES MELLITUS; HEALTH CARE PLANNING; HEALTH INSURANCE; HEART INFARCTION; HUMAN; INFORMATION RETRIEVAL; LABORATORY DIAGNOSIS; MAMMOGRAPHY; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; RISK BENEFIT ANALYSIS; RISK FACTOR; SCREENING; SCREENING TEST; SENSITIVITY AND SPECIFICITY; UNITED STATES; UTERINE CERVIX CANCER;

ADVISORY COMMITTEES; BENCHMARKING; DIAGNOSTIC ERRORS; EARLY DIAGNOSIS; EVIDENCE-BASED MEDICINE; HUMANS; MASS SCREENING; OUTCOME ASSESSMENT (HEALTH CARE); PROGRAM DEVELOPMENT; PROGRAM EVALUATION; UNITED STATES; UNITED STATES PUBLIC HEALTH SERVICE;

EID: 79960481627     PISSN: 0193936X     EISSN: 14786729     Source Type: Journal    
DOI: 10.1093/epirev/mxr005     Document Type: Article

References (48)

1. Charap MH. The periodic health examination: genesis of a myth. Ann Intern Med. 1981;95(6):733-735. (Pubitemid 12248364)
2. Reiser SJ. The emergence of the concept of screening for disease. Milbank Mem Fund Q Health Soc. 1978;56(4): 403-425.
3. Thorner RM, Remein QR. Principles and Procedures in the Evaluation of Screening for Disease. Washington, DC: Government Printing Office; 1961. (Public Health monograph no. 67). (Public Health Service publication no. 846).
4. Wilson JMG, Jungner G. Principles and Practice of Screening for Disease. Geneva, Switzerland:World Health Organization; 1968.
5. Andermann A, Blancquaert I, Beauchamp S, et al. Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years. Bull World Health Organ. 2008; 86(4):317-319. (Pubitemid 351521860)
6. Frame PS, Carlson SJ. A critical review of periodic health screening using specific screening criteria. Part 1: selected diseases of respiratory, cardiovascular, and central nervous systems. J Fam Pract. 1975;2(1):29-36.
7. Friedman GD, Collen MF, Fireman BH. Multiphasic health checkup evaluation: a 16-year follow-up. J Chronic Dis. 1986; 39(6):453-463. (Pubitemid 16044158)
8. The periodic health examination. Canadian Task Force on the Periodic Health Examination. Can Med Assoc J. 1979;121(9): 1193-1254.
9. U.S. Preventive Services Task Force. Guide to Clinical Preventive Services. Baltimore, MD: Williams & Wilkins; 1989.
10. U.S. Preventive Services Task Force. Home Web page. Rockville, MD: USPSTF. (www.USPreventiveservicestaskforce . org). Accessed May 1, 2011.
11. Harris RP, Helfand M,Woolf SH, et al. Current methods of the US Preventive Services Task Force: a review of the process. Methods Work Group, Third US Preventive Services Task Force. Am J Prev Med. 2001;20(suppl 3):21-35. (Pubitemid 33732964)
12. Sawaya GF, Guirguis-Blake J, LeFevre M, et al. Update on the methods of the U.S. Preventive Services Task Force: estimating certainty and magnitude of net benefit. U.S. Preventive Services Task Force. Ann Intern Med. 2007;147(12):871-875. (Pubitemid 351664424)
13. Petitti DB, Teutsch SM, Barton MB, et al. Update on the methods of the U.S. Preventive Services Task Force: insufficient evidence. U.S. Preventive Services Task Force. Ann Intern Med. 2009;150(3):199-205.
14. U.S. Preventive Services Task Force. Procedure Manual. Rockville, MD: US Preventive Services Task Force; July 2008. (AHRQ publication no. 08-05118-EF). (). Accessed May 1, 2011.
15. Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989;81(24):1879-1886. (Pubitemid 20026073)
16. Harris R, Donahue K, Rathore SS, et al. Screening adults for type 2 diabetes: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2003;138(3):215-229. (Pubitemid 36231628)
17. Armstrong K, Moye E, Williams S, et al. Screening mammography in women 40 to 49 years of age: a systematic review for the American College of Physicians. Ann Intern Med. 2007;146(7):516-526. (Pubitemid 351650561)
18. U.S. Preventive Services Task Force. Screening for ovarian cancer: recommendation statement. Ann Fam Med. 2004; 2(3):260-262.
19. Fleming C, Whitlock EP, Beil TL, et al. Screening for abdominal aortic aneurysm: a best-evidence systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2005;142(3):203-211. (Pubitemid 40189113)
20. Levine JS, Ahnen DJ. Clinical practice. Adenomatous polyps of the colon. N Engl J Med. 2006;355(24):2551-2557. (Pubitemid 44917503)
21. Ioannidis JP. Personalized genetic prediction: too limited, too expensive, or too soon? Ann Intern Med. 2009;150(2): 139-141.
22. Wolff T, Guirguis-Blake J, Miller T, et al. Screening for carotid artery stenosis: an update of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2007;147(12):860-870. (Pubitemid 351664428)
23. Harris R. Effectiveness: the next question for breast cancer screening. J Natl Cancer Inst. 2005;97(14):1021-1023. (Pubitemid 41417912)
24. Welch HG. Screening mammography-a long run for a short slide? N Engl J Med. 2010;363(13):1276-1278.
25. US Preventive Services Task Force. Screening for phenylketonuria (PKU). Rockville, MD: U.S. Preventive Services Task Force; 2008. ( uspstf/uspsspku.htm) . Accessed May 1, 2011.
26. Holtzman NA. Expanding newborn screening: how good is the evidence? JAMA. 2003;290(19):2606-2608. (Pubitemid 37443292)
27. Burke W, Psaty BM. Personalized medicine in the era of genomics. JAMA. 2007;298(14):1682-1684. (Pubitemid 47606657)
28. Boustani M, Peterson B, Hanson L, et al. Screening for dementia in primary care: a summary of the evidence for the U.S. Preventive Services Task Force. U.S. Preventive Services Task Force. Ann Intern Med. 2003;138(11):927- 937.
29. Smith-Bindman R, Ballard-Barbash R, Miglioretti DL, et al. Comparing the performance of mammography screening in the USA and the UK. J Med Screen. 2005;12(1):1250-1254.
30. Brewer NT, Salz T, Lillie SE. Systematic review: the longterm effects of false-positive mammograms. Ann Intern Med. 2007;146(7):502-510. (Pubitemid 351650559)
31. Welch HG, Black WC. Overdiagnosis in cancer. J Natl Cancer Inst. 2010;102(9):605-613.
32. Thompson IM, Klotz L. Active surveillance for prostate cancer. JAMA. 2010;304(21):2411-2412.
33. Stone JH. Incidentalomas-clinical correlation and translational science required. N Engl J Med. 2006;354(26):2748-2749. (Pubitemid 43974192)
34. Walter LC, Lindquist K, Nugent S, et al. Impact of age and comorbidity on colorectal cancer screening among older veterans. Ann Intern Med. 2009;150(7):465-473.
35. Mandelblatt JS, Cronin KA, Bailey S, et al. Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms. Breast Cancer Working Group of the Cancer Intervention and Surveillance Modeling Network. Ann Intern Med. 2009;151(10):738-747.
36. Zauber AG, Lansdorp-Vogelaar I, Knudsen AB, et al. Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force. Ann Intern Med. 2008;149(9):659-669.
37. Kulasingam SL, Myers ER, Lawson HW, et al. Costeffectiveness of extending cervical cancer screening intervals among women with prior normal Pap tests. Obstet Gynecol. 2006;107(2 pt 1):321-328.
38. Harris R, Lohr KN. Screening for prostate cancer: an update of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002;137(11):917-929. (Pubitemid 35416628)
39. Gold MR, Siegel JE, Russell LB, et al, Cost-Effectiveness in Health and Medicine. New York, NY: Oxford University Press; 1996.
40. Maciosek MV, Edwards NM, Coffield AB, et al. Priorities among effective clinical preventive services: methods. Am J Prev Med. 2006;31(1):90-96. (Pubitemid 43956596)
41. Quanstrum KH, Hayward RA. Lessons from the mammography wars. N Engl J Med. 2010;363(11):1076-1079.
42. U.S. Preventive Services Task Force. Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2009; 150(6):396-404.
43. Maciosek MV, Coffield AB, Edwards NM, et al. Priorities among effective clinical preventive services: results of a systematic review and analysis. Am J Prev Med. 2006;31(1): 52-61. (Pubitemid 43956597)
44. Schröder FH, Hugosson J, Roobol MJ, et al. Screening and prostate-cancer mortality in a randomized European study. ERSPC Investigators. N Engl J Med. 2009;360(13):1320-1328.
45. Alter MJ, Seeff LB, Bacon BR, et al. Testing for hepatitis C virus infection should be routine for persons at increased risk for infection. Ann Intern Med. 2004;141(9):715-717. (Pubitemid 39434844)
46. Calonge N, Randhawa G. The meaning of the U.S. Preventive Services Task Force grade I recommendation: screening for hepatitis C virus infection. U.S. Preventive Services Task Force. Ann Intern Med. 2004;141(9):718-719. (Pubitemid 39434845)
47. Sackett DL, Holland WW. Controversy in the detection of disease. Lancet. 1975;2(7930):357-359.
48. Welch HG, Albertsen PC. Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005. J Natl Cancer Inst. 2009;101(19): 1325-1329.